Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1072895-84-1

Post Buying Request

1072895-84-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1072895-84-1 Usage

Description

2,4-dichloro-7-Methoxy-6-Methylquinazoline is a quinazoline derivative with a molecular formula C10H8Cl2N2O. It is characterized by the presence of two chlorine atoms, a methoxy group, and a methyl group. This chemical compound is widely used in organic synthesis and medicinal chemistry research, and has demonstrated potential as an anti-cancer agent. Its unique structure and properties make it a valuable compound for the development of new pharmaceuticals and agrochemicals.

Uses

Used in Pharmaceutical Industry:
2,4-dichloro-7-Methoxy-6-Methylquinazoline is used as a key intermediate in the synthesis of various pharmaceuticals. Its unique structure allows for the development of new drugs with improved therapeutic properties.
Used in Agrochemical Industry:
2,4-dichloro-7-Methoxy-6-Methylquinazoline is used as a building block in the synthesis of agrochemicals, contributing to the development of new pesticides and herbicides with enhanced efficacy and selectivity.
Used in Anticancer Research:
2,4-dichloro-7-Methoxy-6-Methylquinazoline is used as a potential anti-cancer agent. Its structure and properties make it a promising candidate for the development of new cancer therapies, offering the potential to target specific cancer cells and inhibit their growth.
Used in Antifungal and Antibacterial Applications:
Due to its demonstrated antifungal and antibacterial activities, 2,4-dichloro-7-Methoxy-6-Methylquinazoline is used in the development of new antimicrobial agents. Its versatility makes it a valuable compound for addressing the growing concerns of antibiotic resistance and the need for new antifungal treatments.

Check Digit Verification of cas no

The CAS Registry Mumber 1072895-84-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,7,2,8,9 and 5 respectively; the second part has 2 digits, 8 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1072895-84:
(9*1)+(8*0)+(7*7)+(6*2)+(5*8)+(4*9)+(3*5)+(2*8)+(1*4)=181
181 % 10 = 1
So 1072895-84-1 is a valid CAS Registry Number.

1072895-84-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 2,4-Dichloro-7-methoxy-6-methylquinazoline

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1072895-84-1 SDS

1072895-84-1Downstream Products

1072895-84-1Relevant articles and documents

Discovery of Potent and Selective Inhibitors for G9a-Like Protein (GLP) Lysine Methyltransferase

Xiong, Yan,Li, Fengling,Babault, Nicolas,Dong, Aiping,Zeng, Hong,Wu, Hong,Chen, Xin,Arrowsmith, Cheryl H.,Brown, Peter J.,Liu, Jing,Vedadi, Masoud,Jin, Jian

, p. 1876 - 1891 (2017/03/17)

G9a-like protein (GLP) and G9a are highly homologous protein lysine methyltransferases (PKMTs) sharing approximately 80% sequence identity in their catalytic domains. GLP and G9a form a heterodimer complex and catalyze mono- and dimethylation of histone H3 lysine 9 and nonhistone substrates. Although they are closely related, GLP and G9a possess distinct physiological and pathophysiological functions. Thus, GLP or G9a selective small-molecule inhibitors are useful tools to dissect their distinct biological functions. We previously reported potent and selective G9a/GLP dual inhibitors including UNC0638 and UNC0642. Here we report the discovery of potent and selective GLP inhibitors including 4 (MS0124) and 18 (MS012), which are >30-fold and 140-fold selective for GLP over G9a and other methyltransferases, respectively. The cocrystal structures of GLP and G9a in the complex with either 4 or 18 displayed virtually identical binding modes and interactions, highlighting the challenges in structure-based design of selective inhibitors for either enzyme.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1072895-84-1